Here are the Form 4 insider transactions from The Scotts Miracle-Gro Company (SMG) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SMG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SMG filings page.
Scotts Miracle-Gro Co. (SMG) reports that President and CEO Nathan Eric Baxter, who is also identified as a director and 10% owner, acquired 23,872 common shares through a grant on October 28, 2026. His directly held position following the grant was 102,315 shares. Baxter also reported an indirect interest of 36,993 common shares through Hagedorn Partnership, L.P.; the footnote describes this as the aggregate proportionate interest of Baxter and family members in Partnership-held shares.
Scotts Miracle-Gro (SMG) EVP, CLO & Corporate Secretary Dimiter Todorov received an award of 9,947 Common Shares on October 28, 2026. The shares were held directly, bringing his directly held position to 28,961 Common Shares. The reported price was $0.00 per share; no Rule 10b5-1 plan is reported.
Scotts Miracle-Gro Co. EVP, CFO & CAO Mark J. Scheiwer acquired 2,163 common shares in a grant/award on October 28, 2026; the reported transaction price was $0.00 per share. After the award, he reported 16,497 common shares held directly. He also reported 562 common shares held indirectly through a 401(k) plan on October 28, 2026.
Scotts Miracle-Gro Co. (SMG) reported that EVP, CFO & CAO Mark J. Scheiwer acquired 13 phantom stock shares on October 26, 2026. His reported direct phantom-stock position afterward was 1,464 shares. Each phantom share represents a right to receive one common share or its cash value; the units are payable in cash following termination of his employment, and he may transfer them to an alternative investment at any time. The transaction listed a per-share amount of $58.74.
Scotts Miracle-Gro (SMG) reported that Mark J. Scheiwer, EVP, CFO & CAO, converted 500 Dividend Equivalent Rights into 500 common shares on October 2, 2026. His reported direct common-share holdings after the transaction were 14,334 shares, rounded from the reported 14,333.684. The amendment adds a transaction inadvertently omitted from the original Form 4. The related award was 3,793 restricted stock units granted on October 2, 2023, and vesting on October 2, 2026.
Scotts Miracle-Gro reported transactions by Mark J. Scheiwer, its EVP, CFO & CAO. On October 2, 2026, 1,559 common shares were delivered or withheld for payment of exercise price or tax liability at $49.02 per share. On September 30, 2026, he acquired 3 common shares at $45.88 per share in an other acquisition. His reported indirect holdings through the 401(K) Plan included 562 shares as of October 2, 2026.
Scotts Miracle-Gro (SMG) director Brian E. Sandoval acquired 575 common shares on October 1, 2026, as deferred stock units issued in lieu of a $28,750 retainer. His reported direct holdings following the award were 20,190 shares.
Scotts Miracle-Gro Co. director Stephen L. Johnson acquired 144 deferred stock units on October 1, 2026, issued in lieu of a $7,188 retainer. His reported direct holdings following the award were 30,323 common shares.
Scotts Miracle-Gro (SMG) EVP, CFO & CAO Mark J. Scheiwer acquired 15 shares of phantom stock as an award on September 28, 2026. His directly held position afterward was 1,451 shares of phantom stock. The award lists a price of 50.27 per share.
Each share of phantom stock represents a right to receive one common share or its cash value. The phantom stock is payable in cash following termination of the reporting person's employment, and he may transfer it into an alternative investment at any time.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Evans David C reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director David C. Evans received an award of 118 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU grants and are the economic equivalent of common shares. Following this award, Evans holds 791 Dividend Equivalent Rights directly. No Rule 10b5-1 trading plan is reported.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Aviles Edith reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director Edith Aviles received a grant of 118 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU grants and are each economically equivalent to one common share, bringing her reported derivative holdings to 791 rights.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Candelino Roberto reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director Roberto Candelino received a grant of 77 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU awards and are economically equivalent to 77 common shares, bringing his directly held Dividend Equivalent Rights to 374.
SCOTTS MIRACLE-GRO CO (SMG) director Austin Scott Miller reported an acquisition of 53 Dividend Equivalent Rights on September 4, 2026. These rights are tied to existing DSU or RSU grants and are economically equivalent to common shares, bringing his directly held Dividend Equivalent Rights balance to 189.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. HAGEDORN KATHERINE LITTLEFIELD reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that director and ten percent owner Katherine Littlefield Hagedorn received a grant of 37 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU awards and are economically equivalent to 37 common shares of the company, bringing her reported Dividend Equivalent Rights holdings to 108.
SCOTTS MIRACLE-GRO CO (SMG) director, President and CEO Nathan Eric Baxter reported a Form 4 transaction involving common shares. On September 5, 2026, 12,023 common shares were delivered or withheld at $57.53 per share to pay an option exercise price or tax liability, leaving 78,442.5948 common shares held directly. He also reports an indirect holding representing a proportionate interest in 36,993 common shares through Hagedorn Partnership, L.P., in which he is a general partner and in which certain family members also hold interests. No Rule 10b5-1 trading plan is indicated.
SCOTTS MIRACLE-GRO CO (SMG) director Peter E. Shumlin reported an acquisition of 170 Dividend Equivalent Rights on September 4, 2026, as a grant or award linked to existing DSU or RSU grants. Each right is the economic equivalent of one common share of the issuer, bringing his directly held Dividend Equivalent Rights to 1,188.
SCOTTS MIRACLE-GRO CO (SMG) director Stephen L. Johnson reported an acquisition of 155 dividend equivalent rights on September 4, 2026. These derivative rights are tied to DSU or RSU grants and bring his directly held dividend equivalent rights to 1,063, each economically equivalent to one common share.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) director Mark D. Kingdon reported an award of 118 Dividend Equivalent Rights on September 4, 2026. These rights accrue on DSU or RSU grants and become exercisable proportionately with those underlying units. Each right is the economic equivalent of one common share, bringing his direct holdings to 791 rights.
SCOTTS MIRACLE-GRO CO (SMG) director Adam Hanft reported an acquisition of derivative-based compensation on September 4, 2026. He received a grant of 118 Dividend Equivalent Rights, each economically equivalent to one common share and tied to existing DSU or RSU grants, bringing his directly held Dividend Equivalent Rights to 791 in total.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that EVP & Chief Brand Officer Nick Miaritis received a grant of 72 Dividend Equivalent Rights on September 4, 2026. These rights, each economically equivalent to one common share, accrued on existing DSU or RSU grants, bringing his directly held dividend equivalent rights to 340.
Scotts Miracle-Gro Co (SMG) reported that its EVP, CFO & CAO, Mark J. Scheiwer, acquired equity-linked awards. On September 4, 2026 he received 15.571 phantom stock units tied to common shares and 47 dividend equivalent rights, and held 1,436.158 phantom units and 500 dividend equivalent rights afterward. Phantom stock is payable in cash after employment termination, and each phantom unit or dividend equivalent right is economically equivalent to one common share. He also reported 2.808 additional common shares on August 31, 2026, for total direct holdings of 15,389.415 common shares plus 493.482 shares held indirectly through a 401(k) plan.
SCOTTS MIRACLE-GRO CO (SMG) executive Christopher Hagedorn, EVP & Chief Strategy Officer, reported an “other” acquisition transaction of 4.063 common shares on August 31, 2026, at a reported price of $53.41 per share. Following this small adjustment, his directly held position is 57,555.9284 common shares.
SCOTTS MIRACLE-GRO CO (SMG) director Brian E. Sandoval reported an acquisition of 179 Dividend Equivalent Rights on September 4, 2026. These rights accrued on existing DSU or RSU grants and are each economically equivalent to one common share of SMG. Following this award, he holds 1,143 Dividend Equivalent Rights directly. No Rule 10b5-1 trading plan is reported in connection with this transaction.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC.
Scotts Miracle-Gro Co director Mark D. Kingdon reported a sale of 831 Common Shares on 2026-08-10 in a non-derivative transaction. The shares were sold at a price of $61.645 per share, leaving him with 10,827 Common Shares held by direct ownership.
Hagedorn Partnership, L.P., a director and 10% owner of Scotts Miracle-Gro, reported sales totaling 30,000 common shares on August 3, 2026, in two transactions of 28,793 and 1,207 shares at weighted-average prices of $67.4234 and $68.1615, within price ranges of $67.00–$67.99 and $68.00–$68.99. The Rule 10b5-1 checkbox was not marked, and the shares are held by the partnership, whose general partners disclaim beneficial ownership except to their pecuniary interest.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, reported an other acquisition of 2.652 Common Shares on July 31, 2026 at $56.55 per share. After this transaction, he directly holds 15,386.607 Common Shares and indirectly holds 493.482 shares through a 401(k) plan.
Scotts Miracle-Gro director, President and CEO Nathan Eric Baxter reported an other acquisition of 88.417 common shares on 2026-07-31 at $56.55 per share. After this transaction he held 90,465.5948 common shares directly and reported an indirect proportionate interest in 36,993 shares held through Hagedorn Partnership, L.P. under Exchange Act Rule 16a-1(a)(1).
Christopher Hagedorn, EVP & Chief Strategy Officer of Scotts Miracle-Gro, reported an acquisition of 3.8370 common shares on 2026-07-31 at $56.55 per share. The event is coded as Form 4 code J, described as an 'Other acquisition or disposition' and classified as a restructuring transaction. After this change, he directly holds 57,551.8654 common shares. The filing indicates the transaction was not made under a Rule 10b5-1 trading plan.
SCOTTS MIRACLE-GRO CO director Stephen L Johnson sold 1,170.9600 Common Shares on July 30, 2026 at $68.3200 per share in a sale described as an open market or private transaction. After this trade, he directly held 30,179.0400 Common Shares.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, received a grant of 3.911 shares of Phantom Stock on 2026-07-27. Each phantom share represents the right to receive one common share or its cash value and is payable in cash after employment terminates. Following this award, Scheiwer holds 1,408.604 Phantom Stock shares directly. The transaction is reported as a grant or award acquisition and is not designated as made under a Rule 10b5‑1 trading plan.
Scotts Miracle-Gro director Stephen L. Johnson received a stock-based compensation award. He acquired 105 Common Shares on July 1, 2026 as a grant, described as a “grant, award, or other acquisition.” The shares were valued at $68.57 each, issued as Deferred Stock Units in lieu of a cash retainer of $7,188.
Following this grant, Johnson directly holds 31,350 Common Shares. This filing reflects routine director compensation paid in stock rather than a market purchase or sale.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, reported routine ownership updates on Common Shares. The Form 4 shows an “other” transaction coded J involving 2.862 shares at $52.4200 per share, leaving him with 15,383.955 Common Shares held directly.
He also reported 493.482 Common Shares held indirectly through a 401(K) Plan. The filing does not show any open-market buys or sells, but rather minor administrative or restructuring activity affecting a small number of shares relative to his total reported holdings.
SCOTTS MIRACLE-GRO CO executive vice president and chief of staff Christopher Hagedorn reported an “other” Form 4 transaction involving 4.14 common shares at $52.42 per share. The event is classified as a restructuring entry and leaves him holding 57,548.0284 common shares directly.
Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO executive Nick Miaritis, EVP & Chief Brand Officer, reported an equity compensation award on a Form 4. He received 16,043 Common Shares at a stated price of $0.00 per share as a grant, rather than an open-market purchase.
Following this award, his direct holdings increased to 22,274 Common Shares. This reflects a routine stock-based compensation grant to a senior officer, not a cash transaction in the market.
SCOTTS MIRACLE-GRO CO President and CEO Nathan Eric Baxter reported equity compensation and ownership updates. On 2026-07-01, he received a grant of 29,168 Common Shares at $0.0000 per share as a “grant, award, or other acquisition,” bringing his direct holdings to 90,377.1778 Common Shares.
A prior 2026-06-30 entry labeled as “other acquisition or disposition” covered 95.383 Common Shares at $52.4200, after which direct holdings were 61,209.1778 Common Shares. He also reports an indirect interest in 36,993.0000 Common Shares held through Hagedorn Partnership, L.P., reflecting his proportionate and family pecuniary interests.
SCOTTS MIRACLE-GRO CO director Brian E. Sandoval received a grant of 420 Common Shares as compensation. The Form 4 shows these Deferred Stock Units were issued in lieu of a cash retainer of $28,750, effectively converting his board fees into equity.
Each unit was valued at $68.57 per share on the grant date. Following this award, Sandoval directly holds 19,615 Common Shares. This is a routine, compensation-related equity grant rather than an open-market share purchase or sale.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, received a small phantom stock award. On this Form 4, he acquired 10.562 shares of phantom stock tied to the company’s common shares at a reference price of $71.01 per share.
Following this grant, Scheiwer holds a total of 1,404.693 phantom stock units directly. Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value, and the units are payable in cash after his employment with the company ends. He may transfer these phantom units into an alternative investment at any time.
HAGEDORN JAMES reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro CEO James Hagedorn received a new compensation award in the form of phantom stock. On this Form 4, he was granted 1,272.152 phantom stock units tied to the company’s common shares at a reference value of $71.01 per unit.
Each phantom stock unit represents the right to receive one common share or its cash value. The units are payable in cash after his employment with the company ends, and he can move them into alternative investments at any time. Following this grant, his reported phantom stock balance is 245,449.926 units.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Stephen L. Johnson received a grant of 158 Dividend Equivalent Rights on common shares. These derivative awards have no purchase price and increase his total Dividend Equivalent Rights holdings to 908. Each right is the economic equivalent of one common share and vests proportionately with the related DSU or RSU grants.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, reported routine equity-related updates. He received 48.0000 Dividend Equivalent Rights and 15.7790 Phantom Stock units on June 5, 2026, both classified as grants or awards tied economically to common shares.
Following these awards, Scheiwer held 15,381.0930 Common Shares directly and 493.4820 Common Shares indirectly through a 401(k) plan, plus 453.0000 Dividend Equivalent Rights and 1,394.1310 Phantom Stock units. The filing also shows a small 2.9680-share "other" common share transaction on May 29, 2026, indicating a minor restructuring rather than open-market trading.
SCOTTS MIRACLE-GRO CO President and COO Nathan Eric Baxter, who is also a more than 10% owner, reported a small "other" transaction in company common shares. On May 29, 2026, a Form 4 entry classified as "other acquisition or disposition" covered 98.951 common shares at $50.53 per share, updating his direct holdings to 61,113.7948 common shares. A separate entry records 36,993 common shares held indirectly through Hagedorn Partnership, L.P., reflecting the aggregate proportionate interest of Baxter and certain family members in that partnership. The filing reflects routine ownership reporting and entity-related restructuring rather than an open-market purchase or sale.
SCOTTS MIRACLE-GRO CO director Peter E. Shumlin received a grant of 173 Dividend Equivalent Rights on Common Shares as compensation. These derivative rights carry no cash exercise price and increase his directly held Dividend Equivalent Rights to 1,018. According to the footnote, the rights accrue on DSU or RSU grants, become exercisable proportionately with those awards, and each right is the economic equivalent of one common share, making this a routine, non-market, equity-based compensation update rather than an open-market stock purchase or sale.
Evans David C reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director David C. Evans received a grant of 121 dividend equivalent rights on June 5, 2026. These rights are tied to existing DSU or RSU awards and are economically equivalent to common shares. After this award, he holds 673 dividend equivalent rights directly.
Aviles Edith reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Edith Aviles received 121 Dividend Equivalent Rights on June 5, 2026 as a compensation-related award. These rights are tied to DSU or RSU grants and each right is economically equal to one common share of the company.
Following this grant, Aviles holds 673 Dividend Equivalent Rights directly. These instruments accrue on deferred or restricted stock units and become exercisable in step with the underlying DSUs or RSUs, so this filing reflects routine equity-based compensation rather than an open-market stock purchase or sale.
Hanft Adam reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Adam Hanft received a grant of 121 Dividend Equivalent Rights tied to existing equity awards. These rights were awarded at no cash cost and increase his derivative holdings to 673 rights. Each Dividend Equivalent Right is the economic equivalent of one common share and accrues on DSU or RSU grants, becoming exercisable in step with those underlying units.
Candelino Roberto reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Roberto Candelino received a compensation-related award of derivative securities. On June 5, 2026, he was granted 79 Dividend Equivalent Rights, each economically equivalent to one common share of the company. These rights accrued on deferred stock unit (DSU) or restricted stock unit (RSU) grants and become exercisable proportionately with the underlying DSUs or RSUs. Following this award, Candelino directly holds 297 Dividend Equivalent Rights linked to common shares.
SCOTTS MIRACLE-GRO CO executive Christopher Hagedorn reported a small administrative share transaction. On May 29, 2026, he recorded an "other" type transaction involving 4.294 Common Shares at $50.53 per share. Following this restructuring-type entry, he directly holds 57,543.8884 Common Shares.
Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Mark D. Kingdon received a grant of 121 Dividend Equivalent Rights. These rights accrued on existing DSU or RSU grants and are economically equivalent to 121 common shares. Following this award, Kingdon directly holds 673 Dividend Equivalent Rights tied to common shares.
Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Nick Miaritis received 74 dividend equivalent rights tied to existing equity awards. These rights were granted as a compensation-related award with no cash price per right. Following the grant, he holds 268 dividend equivalent rights in total, each economically equivalent to one common share and vesting in step with the related DSUs or RSUs.